MEDIFAST INC — Director's Dealing 2023

Feb 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-02-03

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-07	Common Stock	P	11.211	$114.97	Acquired	2377.123	Direct
2023-02-03	Common Stock	P	515.521	$116.11	Acquired	37014.343	Indirect
2023-02-03	Common Stock	P	55.65	$116.11	Acquired	3995.65	Indirect

Footnotes

F1: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F2: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F3: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member.

F4: The shares were acquired by the Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F5: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.